CAS 189060-13-7

LAPAQUISTAT

Descripción:

LAPAQUISTAT, identificado por su número CAS 189060-13-7, es un compuesto químico que funciona principalmente como un agente farmacológico. Es conocido por su papel como un inhibidor selectivo de la enzima acil-CoA:colesterol aciltransferasa (ACAT), que está involucrada en el metabolismo del colesterol. Esta inhibición puede llevar a una reducción en la absorción de colesterol y puede tener implicaciones para el tratamiento de condiciones relacionadas con dislipidemia y enfermedades cardiovasculares. LAPAQUISTAT se caracteriza por su estructura molecular específica, que contribuye a su actividad biológica y selectividad. El compuesto ha sido objeto de varios estudios para evaluar su eficacia y perfil de seguridad en entornos clínicos. Al igual que con muchos agentes farmacéuticos, su uso puede estar asociado con efectos secundarios potenciales, y su farmacocinética, incluyendo absorción, distribución, metabolismo y excreción, son críticas para entender su potencial terapéutico. En general, LAPAQUISTAT representa un área significativa de interés en el desarrollo de terapias para reducir el colesterol.

Fórmula: C₃₃H₄₁ClN₂O₉

InChI: InChI=1S/C33H41ClN2O9/c1-20(37)44-19-33(2,3)18-36-25-10-9-22(34)16-24(25)30(23-7-6-8-26(42-4)31(23)43-5)45-27(32(36)41)17-28(38)35-13-11-21(12-14-35)15-29(39)40/h6-10,16,21,27,30H,11-15,17-19H2,1-5H3,(H,39,40)/t27-,30-/m1/s1

Clave InChI: InChIKey=CMLUGNQVANVZHY-POURPWNDSA-N

SMILES: O(C)C1=C([C@@H]2C=3C(N(CC(COC(C)=O)(C)C)C(=O)[C@@H](CC(=O)N4CCC(CC(O)=O)CC4)O2)=CC=C(Cl)C3)C=CC=C1OC

Sinónimos:

• 1-((1-(3-Acetoxy-2,2-dimethylpropyl)-7-chloro-5-(2,3-dimethoxyphenyl)-2-oxo-1,2\r\n,3,5-tetrahydro-4,1-benzoxazepin-3-yl)acetyl)piperidine-4-acetic acid
• 1-[2-[(3R,5S)-1-[3-(Acetyloxy)-2,2-dimethylpropyl]-7-chloro-5-(2,3-dimethoxyphenyl)-1,2,3,5-tetrahydro-2-oxo-4,1-benzoxazepin-3-yl]acetyl]-4-piperidineacetic acid
• 2-(1-(2-((3R,5S)-1-(3-Acetoxy-2,2-dimethylpropyl)-7-chloro-5-(2,3- dimethoxyphenyl)-2-oxo-1,2,3,5-tetrahydrobenzo(e)(1,4)oxazepin-3- yl)acetyl)piperidin-4-yl)acetic acid
• 4-Piperidineacetic acid, 1-(((3R,5S)-1-(3-(acetyloxy)-2,2-dimethylpropyl)-7- chloro-5-(2,3-dimethoxyphenyl)-1,2,3,5-tetrahydro-2-oxo-4,1-benzoxazepin-3- yl)acetyl)-
• 4-Piperidineacetic acid, 1-[2-[(3R,5S)-1-[3-(acetyloxy)-2,2-dimethylpropyl]-7-chloro-5-(2,3-dimethoxyphenyl)-1,2,3,5-tetrahydro-2-oxo-4,1-benzoxazepin-3-yl]acetyl]-
• 4-Piperidineacetic acid, 1-[[1-[3-(acetyloxy)-2,2-dimethylpropyl]-7-chloro-5-(2,3-dimethoxyphenyl)-1,2,3,5-tetrahydro-2-oxo-4,1-benzoxazepin-3-yl]acetyl]-, (3R-trans)-
• Lapaquistat acetate
• Lapaquistat acetate [USAN]
• Tak 475
• Unii-Iuh3Ay74O3
• Lapaquistat Acetate (TAK-475)
• 1-[[(3R,5S)-1-[3-(Acetyloxy)-2,2-dimethylpropyl]-7-chloro-5-(2,3-dimethoxyphenyl)-1,2,3,5-tetrahydro-2-oxo-4,1-benzoxazepin-3-yl]acetyl]-4-piperidineacetic acid
• CS-1400
• LAPAQUISTAT
• 2-[1-[2-[1-(3-Acetoxy-2,2-diMethylpropyl)-7-chloro-5(S)-(2,3-diMethoxyphenyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3(R)-yl]acetyl]piperidin-4-yl]acetic acid

2-(1-(2-((3R,5S)-1-(3-Acetoxy-2,2-dimethylpropyl)-7-chloro-5-(2,3-dimethoxyphenyl)-2-oxo-1,2,3,5-tetrahydrobenzo[e][1,4]oxazepin-3-yl)acetyl)piperidin-4-yl)acetic acid

CAS: 189060-13-7

2-(1-(2-((3R,5S)-1-(3-Acetoxy-2,2-dimethylpropyl)-7-chloro-5-(2,3-dimethoxyphenyl)-2-oxo-1,2,3,5-tetrahydrobenzo[e][1,4]oxazepin-3-yl)acetyl)piperidin-4-yl)acetic acid

Pureza: 98%

Peso molecular: 645.15g/mol

Ref: 54-OR1062987

Lapaquistat Acetate

Producto controlado

CAS: 189060-13-7

Applications A novel squalene synthase inhibitor. Lapaquistat acetate decreased plasma cholesterol and triglyceride levels, by lowering lipoproteins containing apoB100. Treatment with Lapaquistat acetate increased collagen concentration and transformed coronary plaques into fibromuscular plaques. Lapaquistat acetate also suppressed the expression of matrix metalloproteinase-1 and plasminogen activator inhibitor-1 in the plaque and increased peripheral coenzyme Q10 levels.Antiarteriosclerotics.
References Amano, Y., et al.: Eur. J. Pharmacol., 466, 155 ( 2003), Hiyoshi, H., et al.: J. Lipid Res., 44, 128 (2003), Miki, T., et al.: J. Med. Chem., 45, 4571 (2002), Shiomi, M., et al.: Atherosclerosis, 178, 287 (2005),

Fórmula: C₃₃H₄₁ClN₂O₉

Forma y color: Neat

Peso molecular: 645.14

Ref: TR-L175500

Lapaquistat acetate

CAS: 189060-13-7

LAPAQ is a hydroxyl-containing fatty acid that is synthesized by the liver and is used as a co-therapy for lowering low-density lipoprotein cholesterol. LAPAQ has been shown to have a chemical stability that is 8 times higher than that of other drugs, which may be due to its ester linkages. This drug also has anti-inflammatory properties, which are due to its ability to inhibit the production of high-sensitivity c-reactive protein (hsCRP). LAPAQ inhibits the activity of 3 enzymes involved in cholesterol synthesis, including 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG CoA reductase), acetyl coenzyme A cholesterol acyltransferase (ACAT), and lysophospholipid acyltransferase. It also inhibits the transcriptional regulation of low density lipoprotein cholesterols.

Fórmula: C₃₃H₄₁ClN₂O₉

Pureza: Min. 95%

Peso molecular: 645.14 g/mol

Ref: 3D-PHA06013

Lapaquistat acetate

CAS: 189060-13-7

Lapaquistat acetate (TAK-475) is a squalene synthase inhibitor that reduces the cytotoxicity induced by statins in human skeletal muscle cells.

Fórmula: C₃₃H₄₁ClN₂O₉

Pureza: 99.38% - 99.94%

Forma y color: Solid

Peso molecular: 645.14

Ref: TM-T15709